Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers

被引:17
作者
Cavaliere F. [1 ]
Volpe C. [1 ]
Gargaruti R. [1 ]
Poscia A. [2 ]
Di Donato M. [2 ]
Grieco G. [2 ]
Moscato U. [2 ]
机构
[1] Institute of Anaesthesia and Intensive Care, Catholic University of the Sacred Heart, Rome
[2] Institute of Hygiene, Catholic University of the Sacred Heart, Rome
关键词
Alveolar Ventilation; Deep Inspiration; Exhale Carbon Monoxide; Prolonged Expiration; Photoacoustic Spectrometer;
D O I
10.1186/1471-2466-9-51
中图分类号
学科分类号
摘要
Background: High levels of exhaled carbon monoxide (eCO) are a marker of airway or lung inflammation. We investigated whether hypo- or hyperventilation can affect measured values.Methods: Ten healthy volunteers were trained to achieve sustained end-tidal CO2 (etCO2) concentrations of 30 (hyperventilation), 40 (normoventilation), and 50 mmHg (hypoventilation). As soon as target etCO2 values were achieved for 120 sec, exhaled breath was analyzed for eCO with a photoacoustic spectrometer. At etCO2 values of 30 and 40 mmHg exhaled breath was sampled both after a deep inspiration and after a normal one. All measurements were performed in two different environmental conditions: A) ambient CO concentration = 0.8 ppm and B) ambient CO concentration = 1.7 ppm.Results: During normoventilation, eCO mean (standard deviation) was 11.5 (0.8) ppm; it decreased to 10.3 (0.8) ppm during hyperventilation (p < 0.01) and increased to 11.9 (0.8) ppm during hypoventilation (p < 0.01). eCO changes were less pronounced than the correspondent etCO2 changes (hyperventilation: 10% Vs 25% decrease; hypoventilation 3% Vs 25% increase). Taking a deep inspiration before breath sampling was associated with lower eCO values (p < 0.01), while environmental CO levels did not affect eCO measurement.Conclusions: eCO measurements should not be performed during marked acute hyperventilation, like that induced in this study, but the influence of less pronounced hyperventilation or of hypoventilation is probably negligible in clinical practice. © 2009 Cavaliere et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 36 条
[31]  
Paredi P., Shah P.L., Montuschi P., Sullivan P., Hodson M.E., Kharitonov S.A., Barnes P.J., Increased carbon monoxide in exhaled air of patients with cystic fibrosis, Thorax, 54, pp. 917-920, (1999)
[32]  
Horvath I., Loukides S., Wodehouse T., Csiszer E., Cole P.J., Kharitonov S.A., Barnes P.J., Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia, Thorax, 58, 1, pp. 68-72, (2003)
[33]  
De las Heras D., Fernandez J., Gines P., Cardenas A., Ortega R., Navasa M., Barbera J.A., Calahorra B., Guevara M., Bataller R., Jimenez W., Arroyo V., Rodes J., Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis, Hepatology, 38, 2, pp. 452-459, (2003)
[34]  
Cunnington A.J., Hormbrey P., Breath analysis to detect recent exposure to carbon monoxide, Postgrad Med J, 78, 918, pp. 233-237, (2002)
[35]  
Laranjeira R., Pillon S., Dunn J., Environmental tobacco smoke exposure among nonsmoking waiters: measurement of expired carbon monoxide levels, Sao Paulo Med J, 118, 4, pp. 89-92, (2000)
[36]  
Scharte M., Bone H.G., Van Aken H., Meyer J., Increased carbon monoxide in exhaled air of critically ill patients, Biochem Biophys Res Commun, 267, 1, pp. 423-426, (2000)